Transcriptional regulation of the human reduced folate carrier promoter C: Synergistic transactivation by Sp1 and C/EBP β and identification of a downstream repressor

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1727, Issue 1, 2005, Pages 45-57

  Payton, Scott G ^a   Whetstine, Johnathan R ^a   Ge, Yubin ^b   Matherly, Larry H ^a,b,c  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KARMANOS CANCER INSTITUTE   (United States)

Author keywords

C EBP; Methotrexate; Reduced folate carrier; Sp1; Transcription

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; REDUCED FOLATE CARRIER; TRANSCRIPTION FACTOR SP1;

ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; DROSOPHILA; EXON; GENE ACTIVITY; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REPORTER GENE; REPRESSOR GENE; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; CCAAT-BINDING FACTOR; CCAAT-ENHANCER-BINDING PROTEINS; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; DROSOPHILA; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE TRANSPORT PROTEINS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); SP1 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR CHOP; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 11844257571     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbaexp.2004.11.006     Document Type: Article

References (35)

1. M. Lucock Folic acid: nutritional biochemistry, molecular biology, and role in disease processes Mol. Genet. Metab. 71 2000 121 138
2. L.H. Matherly, and I.D. Goldman Membrane transport of folates Vitam. Horm. 66 2003 403 456
3. G. Jansen Receptor- and carrier-mediated transport systems for folates and antifolates. Exploitation for folate chemotherapy and immunotherapy A.L. Jackman Anticancer Development Guide: Antifolate Drugs in Cancer Therapy 1999 Humana Press Totowa, NJ 293 321
4. L.H. Matherly Molecular and cellular biology of the human reduced folate carrier Prog. Nucleic Acid Res. Mol. Biol. 67 2001 131 161
5. I.D. Goldman, and R. Zhao Molecular, biochemical, and cellular pharmacology of pemetrexed Semin. Oncol. 29 2002 3 17
6. I.D. Goldman, and L.H. Matherly The cellular pharmacology of methotrexate Pharmacol. Ther. 28 1985 77 100
7. J. Jolivet, K.H. Cowan, G.A. Curt, N.J. Clendenin, and B.A. Chabner The pharmacology and clinical use of methotrexate N. Engl. J. Med. 309 1983 1094 1104
8. R.A. Messmann, and C.J. Allegra Antifolates B.A. Chabner D.L. Longo Cancer Chemotherapy and Biotherapy 3rd edition 2001 Lippincott-Raven Philadelphia 139 184
9. L. Paz-Ares, S. Bezares, J.M. Tabernero, D. Castellanos, and H. Cortes-Funes Review of a promising new agent-pemetrexed disodium Cancer 97 2003 2056 2063
10. L. Zhang, J.W. Taub, M. Williamson, S.C. Wong, B. Hukku, J. Pullen, Y. Ravindranath, and L.H. Matherly Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: relationship to immunophenotype and ploidy Clin. Cancer Res. 4 1998 2169 2177
11. R. Gorlick, E. Goker, T. Trippett, P. Steinherz, Y. Elisseyeff, M. Mazumdar, W.F. Flintoff, and J.R. Bertino Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression Blood 89 1997 1013 1018
12. W. Guo, J.H. Healey, P.A. Meyers, M. Ladanyi, A.G. Huvos, J.R. Bertino, and R. Gorlick Mechanisms of methotrexate resistance in osteosarcoma Clin. Cancer Res. 5 1999 621 627
13. J.R. Whetstine, R.M. Flatley, and L.H. Matherly The human reduced folate carrier gene is ubiquitously and differently expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoter Biochem. J. 367 2002 629 640
14. R.M. Flatley, S.G. Payton, J.W. Taub, and L.H. Matherly Primary acute lymphoblastic leukemia cells use a novel promoter and 5′ non-coding exon for the human reduced folate carrier that encodes a modified carrier translated from an upstream translational start Clin. Cancer Res. 10 2004 5111 5122
15. S.J. Roberts, K.N. Chung, K. Nachmanoff, and P.C. Elwood Tissue-specific promoters of the α human folate receptor gene yield transcripts with divergent 5′ leader sequences and different translational efficiencies Biochem. J. 326 1997 439 447
16. L. Chen, H. Qi, J. Korneberg, T.A. Garrow, Y.J. Choi, and B. Shane Purification and properties of human cytosolic folylpoly-glutamate synthetase and organization, localization, and differential splicing of its gene J. Biol. Chem. 271 1996 13077 13087
17. F.B. Turner, J.L. Andreassi, J. Ferguson, S. Titus, A. Tse, S.M. Taylor, and R.G. Moran Tissue-specific expression of functional isoforms of mouse folylpoly-γ-glutamate synthetase: a basis for targeting folate antimetabolites Cancer Res. 59 1999 6074 6079
18. F.B. Turner, S.M. Taylor, and R.G. Moran Expression patterns of multiple transcripts from the folylpolyglutamate synthetase gene in human leukemias and normal differentiated tissues J. Biol. Chem. 275 2000 35960 35968
19. T.A. Kocarek, R.C. Zangar, and R.F. Novak Post-transcriptional regulation of rat CYP2E1 expression: role of CYP2E1 mRNA untranslated regions in control of translational efficiency and message stability Arch. Biochem. Biophys. 376 2000 180 190
20. T. Fiaschi, P. Chiarugi, D. Veggi, G. Raugei, and G. Ramponi The inhibitory effect of the 5′ untranslated region of muscle acylphosphatase mRNA on protein expression is relieved during cell differentiation FEBS Lett. 473 2000 42 46
21. B. Fournier, Q.C. Trunong-Bolduc, X. Zhang, and D.C. Hooper A mutation in the 5′ untranslated region increases stability of norA mRNA, encoding a multidrug resistance transporter of Staphylococcus aureus J. Bacteriol. 183 2001 2367 2371
22. J.R. Whetstine, and L.H. Matherly The basal promoters for the human reduced folate carrier gene are regulated by a GC-box and a cAMP-response element/AP-1-like element J. Biol. Chem. 276 2001 6350 6358
23. J.R. Whetstine, T.L. Witt, and L.H. Matherly The human reduced folate carrier gene is regulated by the Ap2 and Sp1 transcription factor families and a functional 61-base pair polymorphism J. Biol. Chem. 277 2002 43873 43880
24. M. Liu, J.R. Whetstine, S.G. Payton, Y. Ge, R.M. Flatley, and L.H. Matherly Roles of USF, Ikaros, and Sp proteins in the transcriptional regulation of the human reduced folate carrier B promoter Biochem. J. 383 2004 249 257
25. M. Gong, K.H. Cowan, J. Gudas, and J.A. Moscow Isolation and characterization of genomic sequences involved in the regulation of the human reduced folate carrier gene (RFC1) Gene 233 1999 21 31
26. L. Zhang, S.C. Wong, and L.H. Matherly Structure and organization of the human reduced folate carrier gene Biochim. Biophys. Acta 1442 1998 389 393
27. R.M. Horton, Z.L. Cai, S.N. Ho, and L.R. Pease Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction BioTechniques 8 1990 528 535
28. F.M. Ausuble, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl Current Protocols in Molecular Biology vol. 12 1998 John Wiley and Sons New York 1.1 12.1.9
29. Y. Ge, T.L Jensen, L.H. Matherly, and J.W. Taub Transcriptional regulation of human cystathionine beta synthase gene expression in Down syndrome and non-Down syndrome megakaryocytic leukemia cell lines Blood 101 2003 1551 1557
30. Y.H. Lee, M. Yano, S.Y. Liu, E. Matsunaga, P.F. Johnson, and F.J. Gonzalez A novel cis-acting element controlling the rat CYP2D5 gene and requiring cooperativity between C/EBPβ and an Sp1 factor Mol. Cell. Biol. 14 1994 1383 1394
31. C. Lopez-Rodriguez, L. Botella, and A.L. Corbi CCAAT-enhancer-binding proteins (C/EBP) regulate the tissue specific activity of the CD11c integrin gene promoter through functional interactions with Sp1 proteins J. Biol. Chem. 272 1997 29120 29126
32. A.J. Courey, and R. Tjian Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif Cell 55 1988 887 898
33. E. Pascal, and R. Tjian Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism Genes Dev. 5 1991 1646 1656
34. Y.H. Lee, S.C. Willimans, M. Baer, E. Sterneck, F.J. Gonzalez, and P.F. Johnson The ability of C/EBP beta but not C/EBP alpha to synergize with an Sp1 protein is specified by the leucine zipper and activation domain Mol. Cell. Biol. 17 1997 2038 2047
35. D.P. Ramji, and P. Foka CCAAT/enhancer-binding proteins: structure, function and regulation Biochem. J. 365 2002 561 575